Literature DB >> 22205357

Endogenous Tim-1 (Kim-1) promotes T-cell responses and cell-mediated injury in experimental crescentic glomerulonephritis.

Yuji Nozaki1, David J Nikolic-Paterson, Sarah L Snelgrove, Hisaya Akiba, Hideo Yagita, Stephen R Holdsworth, A Richard Kitching.   

Abstract

The T-cell immunoglobulin mucin 1 (Tim-1) modulates CD4(+) T-cell responses and is also expressed by damaged proximal tubules in the kidney where it is known as kidney injury molecule-1 (Kim-1). We sought to define the role of endogenous Tim-1 in experimental T-cell-mediated glomerulonephritis induced by sheep anti-mouse glomerular basement membrane globulin acting as a planted foreign antigen. Tim-1 is expressed by infiltrating activated CD4(+) cells in this model, and we studied the effects of an inhibitory anti-Tim-1 antibody (RMT1-10) on immune responses and glomerular disease. Crescentic glomerulonephritis, proliferative injury, and leukocyte accumulation were attenuated following treatment with anti-Tim-1 antibodies, but interstitial foxp3(+) cell accumulation and interleukin-10 mRNA were increased. T-cell proliferation and apoptosis decreased in the immune system along with a selective reduction in Th1 and Th17 cellular responses both in the immune system and within the kidney. The urinary excretion and renal expression of Kim-1 was reduced by anti-Tim-1 antibodies reflecting diminished interstitial injury. The effects of anti-Tim-1 antibodies were not apparent in the early phase of renal injury, when the immune response to sheep globulin was developing. Thus, endogenous Tim-1 promotes Th1 and Th17 nephritogenic immune responses and its neutralization reduces renal injury while limiting inflammation in cell-mediated glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22205357     DOI: 10.1038/ki.2011.424

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  15 in total

1.  Expression and anatomical distribution of TIM-containing molecules in Langerhans cell sarcoma.

Authors:  Jingwei Li; Dayan Cao; Guoning Guo; Yuzhang Wu; Yongwen Chen
Journal:  J Mol Histol       Date:  2012-12-21       Impact factor: 2.611

2.  Anti-CD45RB Antibody Therapy Attenuates Renal Ischemia-Reperfusion Injury by Inducing Regulatory B Cells.

Authors:  Taishi Fang; Tai Yeon Koo; Jae-Ghi Lee; Joon Young Jang; Yixuan Xu; Ju Hee Hwang; Sunjoo Park; Ji-Jing Yan; Jung-Hwa Ryu; Yeon-Mi Ryu; Sang-Yeob Kim; Kyung-Suk Suh; Jaeseok Yang
Journal:  J Am Soc Nephrol       Date:  2019-07-11       Impact factor: 10.121

3.  Apoptosis inhibitor of macrophage protein enhances intraluminal debris clearance and ameliorates acute kidney injury in mice.

Authors:  Satoko Arai; Kento Kitada; Tomoko Yamazaki; Ryosuke Takai; Xizhong Zhang; Yoji Tsugawa; Ryoichi Sugisawa; Ayaka Matsumoto; Mayumi Mori; Yasunori Yoshihara; Kent Doi; Natsumi Maehara; Shunsuke Kusunoki; Akiko Takahata; Eisei Noiri; Yusuke Suzuki; Naoki Yahagi; Akira Nishiyama; Lakshman Gunaratnam; Tomoko Takano; Toru Miyazaki
Journal:  Nat Med       Date:  2016-01-04       Impact factor: 53.440

4.  A bioinformatics approach identifies signal transducer and activator of transcription-3 and checkpoint kinase 1 as upstream regulators of kidney injury molecule-1 after kidney injury.

Authors:  Amrendra Kumar Ajay; Tae-Min Kim; Victoria Ramirez-Gonzalez; Peter J Park; David A Frank; Vishal S Vaidya
Journal:  J Am Soc Nephrol       Date:  2013-10-24       Impact factor: 10.121

5.  Effect of continuous renal replacement therapy on kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin in patients with septic acute kidney injury.

Authors:  Yiming Shao; Yinqiang Fan; Yuliu Xie; Lu Yin; Yuanli Zhang; Liehua Deng; Xiaocong Sun; Xin Shao; Xinzhang Tan; Junbing He; Shiman Zhao
Journal:  Exp Ther Med       Date:  2017-05-05       Impact factor: 2.447

Review 6.  Blocking monoclonal antibodies of TIM proteins as orchestrators of anti-tumor immune response.

Authors:  Muhammad Baghdadi; Shintaro Takeuchi; Haruka Wada; Ken-Ichiro Seino
Journal:  MAbs       Date:  2014-10-30       Impact factor: 5.857

7.  The pathological role of IL-18Rα in renal ischemia/reperfusion injury.

Authors:  Tomohiro Yano; Yuji Nozaki; Koji Kinoshita; Shoichi Hino; Yasuaki Hirooka; Kaoru Niki; Hideki Shimazu; Kazuya Kishimoto; Masanori Funauch; Itaru Matsumura
Journal:  Lab Invest       Date:  2014-10-20       Impact factor: 5.662

8.  Kim-1/Tim-1 and immune cells: shifting sands.

Authors:  Takaharu Ichimura; Craig R Brooks; Joseph V Bonventre
Journal:  Kidney Int       Date:  2012-05       Impact factor: 10.612

9.  Irreversible renal damage after transient renin-angiotensin system stimulation: involvement of an AT1-receptor mediated immune response.

Authors:  Bart F J Heijnen; Jelly Nelissen; Helma van Essen; Gregorio E Fazzi; Jan W Cohen Tervaert; Carine J Peutz-Kootstra; John J Mullins; Casper G Schalkwijk; Ben J A Janssen; Harry A J Struijker-Boudier
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

10.  T-Cell Expression and Release of Kidney Injury Molecule-1 in Response to Glucose Variations Initiates Kidney Injury in Early Diabetes.

Authors:  Josephine M Forbes; Domenica A McCarthy; Andrew J Kassianos; Tracey Baskerville; Amelia K Fotheringham; Kurt T K Giuliani; Anca Grivei; Andrew J Murphy; Michelle C Flynn; Mitchell A Sullivan; Preeti Chandrashekar; Rani Whiddett; Kristen J Radford; Nicole Flemming; Sam S Beard; Neisha D'Silva; Janelle Nisbet; Adam Morton; Stephanie Teasdale; Anthony Russell; Nicole Isbel; Timothy Jones; Jennifer Couper; Helen Healy; Mark Harris; Kim Donaghue; David W Johnson; Andrew Cotterill; Helen L Barrett; Trisha O'Moore-Sullivan
Journal:  Diabetes       Date:  2021-03-18       Impact factor: 9.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.